BlackRock’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History
Bought
Maintained
Sold
BlackRock's AST.WS Position: Q3 2017 in Review
BlackRock sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 2,856 shares — an estimated $1K sold.
BlackRock first reported a position in AST.WS in Q1 2017 and held it in 2 quarters. The position peaked at $1K in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.
- BlackRock reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
- BlackRock sold 2,856 Asterias Biotherapeutics Warrants shares in Q3 2017, an estimated $1K.
- BlackRock first reported a position in Asterias Biotherapeutics Warrants in Q1 2017 and held it in 2 quarters.
- BlackRock's Asterias Biotherapeutics Warrants position peaked at $1K in Q2 2017.
- 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.
Based on BlackRock's 13F filing for Q3 2017, filed 14 Nov 2017.